Biden Admin Reverses Trump’s Ban On Using Aborted Fetal Tissue For Taxpayer-Funded Research

(Alex Wong/Getty Images)

Daily Caller News Foundation logo
Mary Margaret Olohan Social Issues Reporter
Font Size:

President Joe Biden’s administration has reversed former President Donald Trump’s ban on using abortion fetal tissue for taxpayer-funded research.

The National Institute of Health announced Friday that “HHS is reversing its 2019 decision that all research applications for NIH grants and contracts proposing the use of human fetal tissue from elective abortions will be reviewed by an Ethics Advisory Board.” Health and Human Services Secretary Xavier Becerra had said Thursday that he opposed the Trump administration rules restricting the use of aborted fetal tissue, The Washington Post reported.

“We believe that we have to do the research it takes to make sure that we are incorporating innovation and getting all of those types of treatments and therapies out there to the American people,” Becerra said, the Post reported.

Under Trump’s watch, the U.S. Department of Health and Human Services (HHS) conducted a nine-month review of government-funded research involving fetal tissue from elective abortions. In July 2019, HHS banned the NIH internal research team from using fetal tissue and installed ethics boards to oversee all future federally funded research.

Fetal tissue is used in a number of research projects looking for cures and treatments including Alzheimer’s, spinal cord injury, eye disease and HIV, but religious and pro-life advocates argue the practice is unethical since the fetal tissue comes from aborted babies. (RELATED: Is Fetal Tissue Research Vital To Medicine? Here’s What The Experts Say)

President Joe Biden meets with members of Congress. (Doug Mills/Pool/Getty Images)

President Joe Biden meets with members of Congress. (Doug Mills/Pool/Getty Images)

Pro-life advocates responded to the news with condemnation. Susan B. Anthony List President Marjorie Dannenfelser accused the Biden administration, and Becerra, of “moving rapidly to pay back their abortion industry allies and wipe out pro-life progress made under the Trump-Pence administration.”

“From day one they have sought to expand abortion on demand, funded by taxpayers, against the will of the strong majority of Americans,” Dannenfelser said in a statement. “Now they would force Americans to be complicit in barbaric experiments using body parts harvested from innocent children killed in abortions, with no limits of any kind.” (RELATED: Planned Parenthood Employee Testified She Wanted To ‘Move Forward’ On Selling Fetal Livers For $750 Each)

Dr. Tara Sander Lee of the Charlotte Lozier Institute, SBA List’s research arm, said the decision defies “both the best ethics and most promising science,” noting that  “fetal tissue was not, and has never been, used for polio or any other vaccine, nor  to produce or manufacture any pharmaceutical.”

“There are superior and ethical alternatives available such as adult stem cell models being used by countless scientists worldwide to develop and produce advanced medicines treating patients now, without exploitation of any innocent life,” Lee said. “All scientists should reject the administration’s attempts to prey on fears related to the pandemic to advance the practice of harvesting fetal tissue.”

Biden’s move to reverse Trump’s ban is also at odds with the new president’s Catholic faith: the Catholic Church teaches that abortion is “a crime against human life,” “constitutes a grave offense” and that a person who obtains an abortion is automatically excommunicated from the Catholic Church.

“Such use tends to legitimize abortion as a source of ‘life-affirming’ treatments, and requires collaboration with the abortion industry, which should be avoided,” the United States Conference of Catholic Bishops said in a statement during former President George W. Bush’s administration.

All content created by the Daily Caller News Foundation, an independent and nonpartisan newswire service, is available without charge to any legitimate news publisher that can provide a large audience. All republished articles must include our logo, our reporter’s byline and their DCNF affiliation. For any questions about our guidelines or partnering with us, please contact licensing@dailycallernewsfoundation.org.